Back to Trades
Freeman Jonathan E
DirectorCIK 0001708133
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Freeman Jonathan E, Director, has filed 1 SEC report (2025), all concentrated in Phio Pharmaceuticals Corp. (PHIO), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Sep 15 | PHIO Phio Pharmaceuticals Corp. | Freeman Jonathan E | Director | Grant | $0 |
1 filing